IFP Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

IFP Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,748	Closed	-$96K	–	4221
2018 Q1	$96K	Hold	5,748	–	–	﹤0.01%	1412
2017 Q4	$96K	Buy	5,748 +150	+3%	+$2.75K	﹤0.01%	1424
2017 Q3	$114K	Sell	5,598 -60	-1%	-$1.15K	﹤0.01%	1478
2017 Q2	$91K	Buy	+5,658	New	+$83.6K	﹤0.01%	1577
2017 Q1	–	Sell	-205	Closed	-$3K	–	4261
2016 Q4	$3K	Sell	205 -110	-35%	-$1.88K	﹤0.01%	3588
2016 Q3	$7K	Buy	315 +103	+49%	+$2.77K	﹤0.01%	3103
2016 Q2	$6K	Buy	+212	New	+$6.91K	﹤0.01%	3094
2016 Q1	–	Sell	-7	Closed	–	–	3968
2015 Q4	$0	Buy	+7	New	+$280	﹤0.01%	3859

IFP Advisors's IPXL Position: Q2 2018 in Review

IFP Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 5,748 shares — an estimated $96K sold.

IFP Advisors first reported a position in IPXL in Q4 2015 and held it in 8 quarters. The position peaked at $114K in Q3 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

IFP Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
IFP Advisors sold 5,748 Impax Laboratories, Inc. shares in Q2 2018, an estimated $96K.
IFP Advisors first reported a position in Impax Laboratories, Inc. in Q4 2015 and held it in 8 quarters.
IFP Advisors's Impax Laboratories, Inc. position peaked at $114K in Q3 2017.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.